|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q91143063
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235931.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q91143063
|
|
024
|
|
|
‡a
0000-0003-0790-3133
‡2
orcid
|
|
024
|
|
|
‡a
7201855583
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q91143063
|
|
100
|
0 |
|
‡a
Giuliana Ferrari
‡c
researcher (ORCID 0000-0003-0790-3133)
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Giuliana Ferrari
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Bone marrow as a source of hematopoietic stem cells for human gene therapy of β-thalassemia
|
|
670
|
|
|
‡a
Author's Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
|
|
670
|
|
|
‡a
Author's Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
|
|
670
|
|
|
‡a
Author's Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function
|
|
670
|
|
|
‡a
Author's Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
|
|
909
|
|
|
‡a
(scopus) 7201855583
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000307903133
‡9
1
|
|
919
|
|
|
‡a
mesenchymalcellsappearinginpancreatictissueculturearebonemarrowderivedstemcellswiththecapacitytoimprovetransplantedisletfunction
‡A
Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function
‡9
1
|
|
919
|
|
|
‡a
quantitativelydifferentredcellnucleatedcellchimerisminpatientswithlongtermpersistenthematopoieticmixedchimerismafterbonemarrowtransplantationforthalassemiamajororsicklecelldisease
‡A
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
‡9
1
|
|
919
|
|
|
‡a
intrabonehematopoieticstemcellgenetherapyforadultandpediatricpatientsaffectedbytransfusiondependentssthalassemia
‡A
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
‡9
1
|
|
919
|
|
|
‡a
inhibitionoffgf23isatherapeuticstrategytotargethematopoieticstemcellnichedefectsinβthalassemia
‡A
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
‡9
1
|
|
919
|
|
|
‡a
bonemarrowasasourceofhematopoieticstemcellsforhumangenetherapyofβthalassemia
‡A
Bone marrow as a source of hematopoietic stem cells for human gene therapy of β-thalassemia
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
NTA|096768142
|
|
996
|
|
|
‡2
NUKAT|n 2008107763
|
|
996
|
|
|
‡2
ISNI|0000000432629356
|
|
996
|
|
|
‡2
ISNI|0000000387806455
|
|
996
|
|
|
‡2
J9U|987007281669705171
|
|
996
|
|
|
‡2
BIBSYS|98033524
|
|
996
|
|
|
‡2
RERO|A003239272
|
|
996
|
|
|
‡2
PTBNP|159234
|
|
996
|
|
|
‡2
LC|n 95801276
|
|
996
|
|
|
‡2
BAV|495_173045
|
|
996
|
|
|
‡2
DNB|1063142989
|
|
996
|
|
|
‡2
BNCHL|10000000000000000227947
|
|
996
|
|
|
‡2
SUDOC|132797623
|
|
996
|
|
|
‡2
DNB|127047956
|
|
996
|
|
|
‡2
SUDOC|177126523
|
|
996
|
|
|
‡2
ICCU|CUBV093731
|
|
996
|
|
|
‡2
ISNI|0000000108650348
|
|
996
|
|
|
‡2
SUDOC|243268599
|
|
996
|
|
|
‡2
BAV|495_343033
|
|
996
|
|
|
‡2
SUDOC|088450740
|
|
996
|
|
|
‡2
BAV|495_173050
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
